nach oben

Erschienen in:

03.08.2016 | Original Article

DNA damage after chronic oxytocin administration in rats: a safety yellow light?

verfasst von: Daniela D. Leffa, Francine Daumann, Adriani P. Damiani, Arlindo C. Afonso, Maria A. Santos, Thayara H. Pedro, Renan P. Souza, Vanessa M. Andrade

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Adjuvant therapy is a common therapeutic strategy used for schizophrenia management. Oxytocin has shown promising results as antipsychotic adjuvant in patients with schizophrenia. Although short-term clinical studies have indicated tolerability and no major side-effect manifestation, long-term studies remain needed. In this study, we investigated whether oxytocin chronic administration in rats may lead to brain DNA damage by comet assay. Our results suggest that 21 and 56-day treatment with once daily intraperitoneal oxytocin (0.1, 1.0 and 10.0 mg/kg) may cause substantial DNA damage in hippocampus. We have not found differences on body weight gain. Our findings also point that further clinical and preclinical studies evaluating oxytocin safety after chronic exposure are necessary.

Averbeck BB, Bobin T, Evans S, Shergill SS (2012) Emotion recognition and oxytocin in patients with schizophrenia. Psychol Med 42:259–266. doi:10.1017/S0033291711001413 CrossRefPubMed

Biyikli NK, Tuğtepe H, Sener G, et al. (2006) Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides 27:2249–2257. doi:10.1016/j.peptides.2006.03.029 CrossRefPubMed

Boer GJ (1993) Chronic oxytocin treatment during late gestation and lactation impairs development of rat offspring. Neurotoxicol Teratol 15:383–389CrossRefPubMed

Boyda HN, Tse L, Procyshyn RM, et al. (2010) Preclinical models of antipsychotic drug-induced metabolic side effects. Trends Pharmacol Sci 31:484–497. doi:10.1016/j.tips.2010.07.002 CrossRefPubMed

Bujanow W (1972) Hormones in the treatment of psychoses. Br Med J 4:298CrossRefPubMedPubMedCentral

Bujanow W (1974) Letter: is oxytocin an anti-schizophrenic hormone? Can Psychiatr Assoc J 19:323PubMed

Collins AR (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 26:249–261. doi:10.1385/mb:26:3:249 CrossRefPubMed

Collins A, Dusinská M, Franklin M, et al. (1997) Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 30:139–146CrossRefPubMed

Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214. doi:10.1096/fj.02-0752rev CrossRefPubMed

Feifel D, Reza T (1999) Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology 141:93–98CrossRefPubMed

Feifel D, Macdonald K, Nguyen A, et al. (2010) Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry 68:678–680. doi:10.1016/j.biopsych.2010.04.039 CrossRefPubMed

Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683PubMed

Huang H, Michetti C, Busnelli M, et al. (2014) Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 39:1102–1114CrossRefPubMed

Iqbal Z, Rahman Z, Muhammad F, et al. (2013) Oxytocin induced oxidative stress in lactating Bubalis Bubalis (Nili Ravi. BMC Vet Res 9:169. doi:10.1186/1746-6148-9-169 CrossRefPubMedPubMedCentral

Ito T, Ando H, Suzuki T, et al. (2010) Identification of a primary target of thalidomide teratogenicity. Science 327:1345–1350. doi:10.1126/science.1177319 CrossRefPubMed

Kuehn BM (2011) Scientists probe oxytocin therapy for social deficits in autism, schizophrenia. JAMA 305:659–661. doi:10.1001/jama.2011.117 CrossRefPubMed

Lee S-Y, Park S-H, Chung C, et al. (2015) Oxytocin protects hippocampal memory and plasticity from uncontrollable stress. Sci Rep 5:18540. doi:10.1038/srep18540 CrossRefPubMedPubMedCentral

Lepping P, Delieu J, Mellor R, et al. (2011) Antipsychotic medication and oxidative cell stress: a systematic review. J Clin Psychiatry 72:273–285. doi:10.4088/JCP.09r05268yel CrossRefPubMed

Leucht S, Heres S, Kissling W, Davis JM (2011) Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol 14:269–284. doi:10.1017/S1461145710001380 CrossRefPubMed

Mairesse J, Gatta E, Reynaert ML, Marrocco J, Morley-Fletcher S, Soichot M, Deruyter L, Camp GV, Bouwalerh H, Fagioli F, Pittaluga A, Allorge D, Nicoletti FMS (2015) Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats. Psychoneuroendocrinology 62:36–46. doi:10.1016/j.psyneuen.2015.07.00 CrossRefPubMed

Miyamoto S, Miyake N, Jarskog LF, et al. (2012) Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry 17:1206–1227. doi:10.1038/mp.2012.47 CrossRefPubMed

Moraes MCS, Neto JBC, Menck CFM (2012) DNA repair mechanisms protect our genome from carcinogenesis. Front Biosci 17:1362–1388CrossRef

Neumann ID, Slattery D (2016) Oxytocin in general anxiety and social fear: a translational approach. Biol Psychiatry 79:213–221. doi:10.1016/j.biopsych.2015.06.004 CrossRefPubMed

Pedersen CA, Gibson CM, Rau SW, et al. (2011) Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophr Res 132:50–53. doi:10.1016/j.schres.2011.07.027 CrossRefPubMed

Peters S, Slattery D, Uschold-Schmidt N, et al. (2014) Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 42:225–236. doi:10.1016/j.psyneuen.2014.01.021 CrossRefPubMed

Sánchez JPB, Ellenbroek BA (2016) Preclinical Effects of Antipsychotic Drugs. Curr Top Behav Neurosci. doi:10.1007/7854_2016_447 PubMed

Simsek Y, Celik O, Karaer A, et al. (2012) Elevated cardiac oxidative stress in newborn rats from mothers treated with atosiban. Arch Gynecol Obstet 285:655–661. doi:10.1007/s00404-011-2069-5 CrossRefPubMed

Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191CrossRefPubMed

Souza RP, de Luca V, Meltzer HY, et al. (2010) Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes. Int J Neuropsychopharmacol 13:793–798. doi:10.1017/S1461145710000167 CrossRefPubMed

Szeto A, Nation DA, Mendez AJ, et al. (2008) Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 295:E1495–E1501. doi:10.1152/ajpendo.90718.2008 CrossRefPubMedPubMedCentral

Tice RR, Agurell E, Anderson D, et al. (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221CrossRefPubMed

Titel: DNA damage after chronic oxytocin administration in rats: a safety yellow light?
verfasst von: Daniela D. Leffa
Francine Daumann
Adriani P. Damiani
Arlindo C. Afonso
Maria A. Santos
Thayara H. Pedro
Renan P. Souza
Vanessa M. Andrade
Publikationsdatum: 03.08.2016
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 1/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-016-9885-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

DNA damage after chronic oxytocin administration in rats: a safety yellow light?

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Reduced neurotrophic factor level is the early event before the functional neuronal deficiency in high-fat diet induced obese mice

Investigation of the protective effect of Paeonia lactiflora on Semen Strychni-induced neurotoxicity based on monitoring nine potential neurotoxicity biomarkers in rat serum and brain tissue

Estrogen-like neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ERα

Neuroprotective effect of Cucumis melo Var. flexuosus leaf extract on the brains of rats with streptozotocin-induced diabetes

Vegetarian diet and excessive tea consumption: a dangerous association?

Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie